1e
19
1
49
2
2
18
1b
1d
18
3c
72
1d
2 29
1d
25
Heidi S. Harvie, MBA, MD, MSCE
78
72
Associate Professor of Obstetrics and Gynecology at the Pennsylvania Hospital
28
6e
3
70
Senior Fellow, Leonard Davis Institute of Health Economics,
30
University of Pennsylvania, The Wharton School
23
, University of Pennsylvania
80
Director of Urogynecology at Pennsylvania Hospital, Pennsylvania Hospital
67
Chief, Urogynecology, University of Pennsylvania
11
Department: Obstetrics and Gynecology
4
1
b
1d
46
Contact information
43
4
3
3
3
2
4
b
1f
43
Pennsylvania Hospital
37 Urogynecology and Pelvic Reconstructive Surgery
51 Penn Medicine at Washington Square, 10th floor
Philadelphia, PA 19107
26
37 Urogynecology and Pelvic Reconstructive Surgery
51 Penn Medicine at Washington Square, 10th floor
Philadelphia, PA 19107
35
f
13
Education:
21 b B.B.A. 34 (Accounting/Management - magna cum laude) c
59 University of Pennsylvania, The Wharton School, Philadelphia, PA, 1989.
21 9 M.D. c
58 University of Pennsylvania School of Medicine, Philadelphia, PA, 2002.
21 b M.B.A. 38 (Business Admin in Health Care - with honors) c
59 University of Pennsylvania, The Wharton School, Philadelphia, PA, 2002.
21 d M.S.C.E. c
58 University of Pennsylvania School of Medicine, Philadelphia, PA, 2009.
c
3
3
3
3
8b
Permanent link21 b B.B.A. 34 (Accounting/Management - magna cum laude) c
59 University of Pennsylvania, The Wharton School, Philadelphia, PA, 1989.
21 9 M.D. c
58 University of Pennsylvania School of Medicine, Philadelphia, PA, 2002.
21 b M.B.A. 38 (Business Admin in Health Care - with honors) c
59 University of Pennsylvania, The Wharton School, Philadelphia, PA, 2002.
21 d M.S.C.E. c
58 University of Pennsylvania School of Medicine, Philadelphia, PA, 2009.
c
2 29
21
1e
1d
24
2b
29
27
23
12c Agrawal, S., Ikpeama, N., Koelper, N., Dokras, A., Harvie, H., Hamm, R. F., Dutcher, L., & Arya, L. A.: A Randomized Trial of a Texting Platform for Recurrent Urinary Tract Infections. Urogynecology 32(3): 62–171, March 2026.
179 Lukacz ES, Menefee SA, Carper B, Collins S, McMillian K, Florian-Rodriguez M, Rardin C, Weidner AC, Harvie HS, Alexander B, Mazloomdoost D, NICHD Pelvic Floor Disorders Network: Design of Transurethral Bulking Agent Injection Versus Single-Incision SlingTrial. Urogynecology 32(2): 131–141, Feb 2026.
d8 Harvie HS, Chermansky C, Richter HE: Midurethral Sling vs OnabotulinumtoxinA for Urinary Incontinence-Reply. JAMA 334(16): 1488-1489, Oct 2025.
f5 Muñoz JM, Kim EK, Andy UU, Mumford SL, Harvie HS: Variation in Overactive Bladder Treatment Type by Social Determinants of Health. Urogynecology 31(10): 929-941, Oct 2025.
14a Walter JR, Richards EG, Johannesson L, Falcone T, Testa G, O'Neill KE, Harvie HS: Cost-effectiveness Analysis of Uterus Transplantation versus Gestational Carrier for Treatment of Absolute Uterine Factor Infertility. Fertil Steril 124(1): 121-133, Jul 2025.
11c Reaves S, Levin, PJ, Harvie HS, Andy UU: Factors Affecting Follow-up for Specialty Postpartum Care after Obstetric Anal Sphincter Injury at a Single U.S. Institution. Int Urogynecol J 36(7): 1457-1463, Jul 2025.
1b4 Harvie HS, Menefee SA, Richter HE, Sung VW, Chermansky CJ, Rahn DD, Amundsen CL, Arya LA, Rhodes E, Mazloomdoost D, Thomas S, National Institute of Child Health and Human Development Pelvic Floor Disorders Network: Midurethral Sling vs OnabotulinumtoxinA in Females With Urinary Incontinence: The MUSA Randomized Clinical Trial. JAMA 333(21): 1887-1896, Jun 2025.
fa Arya LA, Agrawal S, Ikpeama N, Harvie HS, Feldman RH, Dutcher L: Implementing a Digital Platform for Recurrent Urinary Tract Infections. Urogynecology 31(3): 183-193, Mar 2025.
136 CX Hong , M O'Leary, W Horner, PC Schmidt, HS Harvie, NS Kamdar, DM Morgan: Decreasing Utilization of Vaginal Hysterectomy in the United States: An Analysis by Candidacy for Vaginal Approach. Int Urogynecol J 35(10): 1983-1991, Oct 2024.
2c
7
1d
1f
Selected Publications
130 Gilmore E, McAllister A, Russell LB, Montoya M, Koelper NC, Schreiber CA, Harvie HS: Validity and Responsiveness of EQ-5D-5L in the Abortion Care Setting. American journal of obstetrics and gynecology 234(4): 1121–1129, Apr 2026.12c Agrawal, S., Ikpeama, N., Koelper, N., Dokras, A., Harvie, H., Hamm, R. F., Dutcher, L., & Arya, L. A.: A Randomized Trial of a Texting Platform for Recurrent Urinary Tract Infections. Urogynecology 32(3): 62–171, March 2026.
179 Lukacz ES, Menefee SA, Carper B, Collins S, McMillian K, Florian-Rodriguez M, Rardin C, Weidner AC, Harvie HS, Alexander B, Mazloomdoost D, NICHD Pelvic Floor Disorders Network: Design of Transurethral Bulking Agent Injection Versus Single-Incision SlingTrial. Urogynecology 32(2): 131–141, Feb 2026.
d8 Harvie HS, Chermansky C, Richter HE: Midurethral Sling vs OnabotulinumtoxinA for Urinary Incontinence-Reply. JAMA 334(16): 1488-1489, Oct 2025.
f5 Muñoz JM, Kim EK, Andy UU, Mumford SL, Harvie HS: Variation in Overactive Bladder Treatment Type by Social Determinants of Health. Urogynecology 31(10): 929-941, Oct 2025.
14a Walter JR, Richards EG, Johannesson L, Falcone T, Testa G, O'Neill KE, Harvie HS: Cost-effectiveness Analysis of Uterus Transplantation versus Gestational Carrier for Treatment of Absolute Uterine Factor Infertility. Fertil Steril 124(1): 121-133, Jul 2025.
11c Reaves S, Levin, PJ, Harvie HS, Andy UU: Factors Affecting Follow-up for Specialty Postpartum Care after Obstetric Anal Sphincter Injury at a Single U.S. Institution. Int Urogynecol J 36(7): 1457-1463, Jul 2025.
1b4 Harvie HS, Menefee SA, Richter HE, Sung VW, Chermansky CJ, Rahn DD, Amundsen CL, Arya LA, Rhodes E, Mazloomdoost D, Thomas S, National Institute of Child Health and Human Development Pelvic Floor Disorders Network: Midurethral Sling vs OnabotulinumtoxinA in Females With Urinary Incontinence: The MUSA Randomized Clinical Trial. JAMA 333(21): 1887-1896, Jun 2025.
fa Arya LA, Agrawal S, Ikpeama N, Harvie HS, Feldman RH, Dutcher L: Implementing a Digital Platform for Recurrent Urinary Tract Infections. Urogynecology 31(3): 183-193, Mar 2025.
136 CX Hong , M O'Leary, W Horner, PC Schmidt, HS Harvie, NS Kamdar, DM Morgan: Decreasing Utilization of Vaginal Hysterectomy in the United States: An Analysis by Candidacy for Vaginal Approach. Int Urogynecol J 35(10): 1983-1991, Oct 2024.
2c